IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Karyopharm Therapeutics

CUSIP: 48576UAA4 | TRACE | 38 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2025

Affinity Asset Advisors, LLC15,250,000
1.1% of portfolio›$12.5M
Opaleye Management Inc.6,000,000
0.7% of portfolio›$4.6M
Exome Asset Management LLC2,000,000
1.0% of portfolio›$1.6M
BLB&B Advisors, LLC75,000
0.0% of portfolio›$60.5K
JPMorgan Chase & Co38,000
0.0% of portfolio›$37.3K
StyleTurnoverLocationFiled
Affinity Asset Advisors, LLC
15,250,000$12.5M1.1%Deep ValueHighNew York, NY2025-11-13
Opaleye Management Inc.
6,000,000$4.6M0.7%Agg GrowthMediumBoston, MA2025-11-14
Exome Asset Management LLC
2,000,000$1.6M1.0%CoreHighNew York, NY2025-11-14
BLB&B Advisors, LLC
75,000$60.5K0.0%ETFLowMontgomeryville, PA2025-10-31
JPMorgan Chase & Co
38,000$37.3K0.0%GrowthMediumNew York, NY2025-11-26